VOLUME XXI  No. 56 T H U R S D A Y March 14, 2019

 

 

 

 

 

HUA  HAN  HEALTH  INDUSTRY  HOLDINGS  LTD:

THE  CHAIRMAN  IS  SUED  FOR  ABOUT  $HK491  MILLION

 

 

The Chairman of Hua Han Health Industry Holdings Ltd (華瀚健康產業控股有限公司) (Code: 587, Main Board, The Stock Exchange of Hongkong Ltd) has been sued in the High Court of the Hongkong Special Administrative Region (HKSAR) of the People’s Republic of China (PRC) for $HK490,887,777.00 plus interest and costs.

 

He is Mr Zhang Yue (張岳)1, alias Mr Zhang Peter Y., aged about 57 years, described in the 2014/2015 Annual Report of Hua Han Health Industry Holdings Ltd with regard to the Financial Year, ended June 30, 2015, as being, inter alia, ‘the Chairman of the Company and one of the Founders’ having graduated from  Guiyang Teacher Training College (貴陽師範學院) in 1982 with a Bachelor Degree in Chemistry. Mr Zhang Peter Y. has been appointed as a standing member of the Fifth Chinese People’s Political Consultative Conference in Yunyan District of Guiyang City (貴陽市雲岩區第五屆政協常委).’

 

In HKSAR, High Court Action, Number 378 of 2019, Haitong International Financial Products Ltd (海通國際金融產品有限公司), the Plaintiff, has sued Mr Zhang Yue as the First Defendant, claiming $US62,887,777 (equivalent at the today’s foreign-exchange, translation rate of about $HK490,887,777.00.)

 

The Plaintiff is a wholly owned subsidiary of Haitong International Securities Group Ltd (海通國際證券集團有限公司) (Code: 665, Main Board, The Stock Exchange of Hongkong Ltd), according to the database of TOLFIN (泰達資訊), the Computerised, Online Financial Intelligence Service and Web-Based, Credit-Checking Provider.

 

The other Four Defendants are:

 

Mr Deng Jie ()2

Second Defendant

 

 

Main Union Investment Ltd

Third Defendant

 

 

Intended Features Ltd 3

Fourth Defendant

 

 

Grand Motion Development Ltd

Fifth Defendant

                       

 

EDITOR’S NOTES

 

1.      Mr Zhang Yue is a controlling shareholder of Hua Han Health Industry Holdings Ltd and a director of Bull’s-Eye Ltd, a controlling shareholder of the Company. As at June 30, 2015, Mr Zhang Yue was said to be interested in approximately 26.29 percent of the Issued and Fully Paid-Up Share Capital and Underlying Shares of the Company.

 

2.      Mr Deng Jie, aged about 55 years, is, in the 2014/2015 Annual Report of Hua Han Health Industry Holdings Ltd, described as being ‘the Chief Executive Officer and an executive Director of the Company’, and one of the Co-Founders. He was appointed as a member of the Eighth and the Ninth Chinese People’s Political Consultative Conference in Guizhou (貴州省第八屆及第九屆政協委員) since 1998. Mr Deng Jie is a director of Bull’s-Eye Ltd, a controlling shareholder of the Company. As at June 30, 2015, Mr Deng Jie was said to be interested in approximately 0.06 percent of the Issued and Fully Paid-Up Share Capital the Underlying Shares of the Company.

 

3.      Intended Features Ltd is a wholly owned subsidiary of Hua Han Health Industry Holdings Ltd, according to TOLFIN’s database.

 

In respect of the 2014/2015 Financial Year, Hua Han Health Industry Holdings Ltd was named Hua Han Bio-Pharmaceutical Holdings Ltd (華瀚生物製藥控股有限公司). With effect from December 21, 2015, the Company changed its name to Hua Han Health Industry Holdings Ltd.

 

In the ... CLICK  TO  ORDER  FULL  ARTICLE

 

 

 

While TARGET makes every attempt to ensure accuracy of all data published, 
TARGET cannot be held responsible for any errors and/or omissions.

 

If readers feel that they would like to voice their opinions about that which they have read in TARGET, please feel free to e-mail your views to editor@targetnewspapers.com. TARGET does not guarantee to publish readers' views, but reserves the right so to do subject to the laws of libel.